Variant report
Variant | esv2752610 |
---|---|
Chromosome Location | chr3:109906409-109918190 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs543956915 | chr3:109907202-109907203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs6793709 | chr3:109907226-109907227 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs532763105 | chr3:109907244-109907245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs6793802 | chr3:109907266-109907267 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs566425992 | chr3:109907332-109907333 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs528775197 | chr3:109907368-109907369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs6769312 | chr3:109907396-109907397 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs140548629 | chr3:109907414-109907415 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs536612808 | chr3:109907449-109907450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs552007012 | chr3:109907454-109907455 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs567141945 | chr3:109907468-109907469 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs6769411 | chr3:109907527-109907528 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs112457514 | chr3:109907548-109907549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs372038542 | chr3:109907550-109907551 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs78812085 | chr3:109907562-109907563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs549443093 | chr3:109907574-109907575 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs141597747 | chr3:109907586-109907587 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs573094274 | chr3:109907593-109907594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs57224506 | chr3:109907600-109907601 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs546299016 | chr3:109908432-109908433 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs559567254 | chr3:109908443-109908444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs376058762 | chr3:109908453-109908454 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs573399478 | chr3:109908479-109908480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs181610256 | chr3:109908499-109908500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs572213476 | chr3:109908500-109908501 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs62283741 | chr3:109908528-109908529 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs542015903 | chr3:109908572-109908573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs36025553 | chr3:109908579-109908580 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs562405749 | chr3:109908610-109908611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs140900962 | chr3:109908647-109908648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs536532566 | chr3:109908656-109908657 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs554596466 | chr3:109908672-109908673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs576919951 | chr3:109908745-109908746 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs563722107 | chr3:109908746-109908747 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs532891569 | chr3:109908754-109908755 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs144136464 | chr3:109908782-109908783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs566405361 | chr3:109908822-109908823 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs535643281 | chr3:109908827-109908828 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs1350857 | chr3:109908846-109908847 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs55801320 | chr3:109908872-109908873 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs538125010 | chr3:109908876-109908877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs557422240 | chr3:109908894-109908895 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs577334745 | chr3:109908895-109908896 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs539810218 | chr3:109908911-109908912 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs374865305 | chr3:109908915-109908916 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs577034479 | chr3:109908929-109908930 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs367660681 | chr3:109909006-109909007 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs113527961 | chr3:109909019-109909020 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs1350856 | chr3:109909049-109909050 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs115627358 | chr3:109909054-109909055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Developmental delay | 22180640 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:109907200-109907400 | Weak transcription | Right Ventricle | heart |
2 | chr3:109907400-109907600 | Enhancers | Right Ventricle | heart |
3 | chr3:109908400-109912000 | Weak transcription | Placenta Amnion | Placenta Amnion |
4 | chr3:109911200-109913200 | Enhancers | Fetal Heart | heart |
5 | chr3:109912000-109913400 | Enhancers | Placenta Amnion | Placenta Amnion |
6 | chr3:109917600-109918200 | Enhancers | Brain Germinal Matrix | brain |
7 | chr3:109917800-109918200 | Enhancers | Right Ventricle | heart |
8 | chr3:109917800-109918600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |